Trial intelligence / Profile preview

Propofol Dose Comparison for Hemodynamic Stability During Anesthesia Induction

NCT03861364Phase 4Completed

Sponsor
Helse Fonna
Start
Sep 2019
Primary completion
May 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of propofol in hemodynamic instability (2 arms), sponsored by Helse Fonna. Primary endpoints: Systolic blood pressure at 7.5 minutes and Heart rate at 7.5 minutes. Started Sep 2019; status: completed.

02

Drugs

propofol
03

Conditions

hemodynamic instability

Beyond the preview

Go deeper on NCT03861364.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03861364.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call